insights_auto
Outlook: 67.5% bullish·5.0% bearish
Go to analysischevron_right
AZN:LON
AstraZeneca
12 506,00 GBX
arrow_downward
-1,51%(-192,00) 1D
16 ოქტ, 17:15:00 GMT+1 · GBX
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AZN...
Open
12 506,00 GBX
High
12 576,00 GBX
Low
12 418,00 GBX
Mkt. cap
259,57 მლრ.
Avg. vol.
2,88 მლნ.
Volume
2,88 მლნ.
Dividend
1,91%
Quarterly dividend
59,75 GBX
Ex-dividend date
6 აგვ. 2026
P/E ratio
24,78
52-wk high
15 732,00 GBX
52-wk low
9 892,00 GBX
EPS
5,05 GBX
Shares outstanding
1,55 მლრდ.
No. of employees
96 ათ.
Open
12 506,00 GBX
High
12 576,00 GBX
Low
12 418,00 GBX
Mkt. cap
259,57 მლრ.
Avg. vol.
2,88 მლნ.
Volume
2,88 მლნ.
Dividend
1,91%
Quarterly dividend
59,75 GBX
Ex-dividend date
6 აგვ. 2026
P/E ratio
24,78
52-wk high
15 732,00 GBX
52-wk low
9 892,00 GBX
EPS
5,05 GBX
Shares outstanding
1,55 მლრდ.
No. of employees
96 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
10 საათის წინ
AstraZeneca stock: RBC keeps GBp 14,500 target for AstraZeneca stock
Insider Monkey
·
10 საათის წინ
AstraZeneca’s Shares Have Fallen, but Is 14.6x Forward Earnings a Buying Opportunity?
The Statesman
·
10 საათის წინ
Fadnavis praises AstraZeneca for opening Mumbai office, thanks pharma company for COVID-19 vaccine
Traders Union
·
17 საათის წინ
AstraZeneca shares technical analysis: Upward price move confirms strong near-term momentum
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About AstraZeneca
CEOPascal Soriot
Employees96,1 ათ.
Founded6 აპრ. 1999
Headquartersკემბრიჯი, Cambridgeshire, გაერთიანებული სამეფო
SectorPharmaceutical industry
Websiteastrazeneca.com